PETER MCDONNELL
Medical Practice at Wolfe St, Baltimore, MD
License number
Maryland D32655
Category
Medical Practice
Type
Ophthalmology
Address
Address
600 N Wolfe St, Baltimore, MD 21287
Phone
(443) 287-1511
Personal information
See more information about PETER MCDONNELL at radaris.comName
Address
Phone
5008 Gold Hill Rd, Owings Mills, MD 21117
960 Fell St UNIT 512, Baltimore, MD 21231
5008 Gold Hill Rd, Owings Mills, MD 21117
5008 Gold Hill Rd Owings, Pikesville, MD 21208
6304 Walhonding Rd, Bethesda, MD 20816
Organization information
See more information about PETER MCDONNELL at bizstanding.comPeter McDonnell MD
600 N Wolfe St, Baltimore, MD 21287
Industry:
Ophthalmology
Phone:
(443) 287-1511 (Phone)
Peter J. Mcdonnell Iii
Professional information
Co- Owner, Executive Vice President At Kcw Engineering Technologies, Inc.
Position:
Co-Owner, Executive Vice President at KCW Engineering Technologies, Inc.
Location:
Baltimore, Maryland Area
Industry:
Civil Engineering
Work:
KCW Engineering Technologies, Inc.
- Maryland and Washington, DC since Jul 1986
-
Co-Owner, Executive Vice President
Education:
Presentation Brothers College Cork
University College Cork
BE, Civil Engineering
University College Cork
BE, Civil Engineering
Peter J McDonnell, Baltimore MD
Specialties:
Ophthalmologist
Address:
600 N Wolfe St, Baltimore, MD 21287
600 N Wolfe, Baltimore, MD 21287
600 N Wolfe, Baltimore, MD 21287
Education:
Johns Hopkins University, School of Medicine - Doctor of Medicine*
Johns Hopkins Hospital - Residency - Ophthalmology*
Johns Hopkins Hospital - Residency - Ophthalmology*
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology*
Peter J McDonnell, Baltimore MD
Specialties:
Ophthalmology, Pediatric Ophthalmology, Geriatric Psychiatry
Work:
Johns Hopkins University
600 N Wolfe St, Baltimore, MD 21287 Jhu
601 N Caroline St, Baltimore, MD 21287
600 N Wolfe St, Baltimore, MD 21287 Jhu
601 N Caroline St, Baltimore, MD 21287
Education:
Johns Hopkins University (1982)
Drug Loaded Microfiber Sutures For Ophthalmic Application
US Patent:
2013029, Nov 7, 2013
Filed:
May 6, 2013
Appl. No.:
13/888164
Inventors:
Justin Hanes - Baltimore MD, US
Hai-Quan Mao - Baltimore MD, US
Peter John McDonnell - Baltimore MD, US
Himatkumar Patel - Baltimore MD, US
Murilo W. Rodrigues - Baltimore MD, US
Qingguo Xu - Baltimore MD, US
Shuming Zhang - Baltimore MD, US
Hai-Quan Mao - Baltimore MD, US
Peter John McDonnell - Baltimore MD, US
Himatkumar Patel - Baltimore MD, US
Murilo W. Rodrigues - Baltimore MD, US
Qingguo Xu - Baltimore MD, US
Shuming Zhang - Baltimore MD, US
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
A61L 17/00
US Classification:
606231
Abstract:
Ophthalmic suture materials made from biocompatible and biodegradable polymers with high tensile strength for use in drug delivery, methods of making them, and method of using them for ocular surgery and repair have been developed. The suture materials are made from a combination of a biodegradable, biocompatible polymer and a hydrophilic biocompatible polymer. In a preferred embodiment the suture materials are made from a poly(hydroxyl acid) such as poly(l-lactic acid) and a polyalkylene oxide such as poly(ethylene glycol) or a polyalkylene oxide block copolymer. The sutures entrap (e.g., encapsulate) one or more therapeutic, prophylactic or diagnostic agents and provide prolonged release over a period of at least a week, preferably a month.
Sustained Delivery Of Therapeutic Agents To An Eye Compartment
US Patent:
2012032, Dec 20, 2012
Filed:
Feb 25, 2011
Appl. No.:
13/581454
Inventors:
Peter J. McDonnell - Baltimore MD, US
Yasin A. Khan - Baltimore MD, US
Samuel K. Lai - Baltimore MD, US
Ashley Behrens - Baltimore MD, US
Justin S. Hanes - Baltimore MD, US
Yasin A. Khan - Baltimore MD, US
Samuel K. Lai - Baltimore MD, US
Ashley Behrens - Baltimore MD, US
Justin S. Hanes - Baltimore MD, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
A61K 9/14, A61K 31/56, A61P 27/02, A61K 39/395
US Classification:
424497, 424490, 4241301, 514169
Abstract:
Compositions and methods for treating eye disorders by administering a drug delivery system into an eye compartment of the patient, wherein the drug delivery system contains a particle containing a core; a coating associated with the particle, wherein the wherein the coating is covalently or non-covalently associated with the particle and presents a hydrophilic region to the environment around the particle; and a therapeutic agent are disclosed. The eye compartment can exhibit reduced inflammation or IOP after administration of the drug delivery systems to a patient than if a drug delivery system including an uncoated particle were administered to the patient.